Summary of project PR001035

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR001035. The data can be accessed directly via it's Project DOI: 10.21228/M8X39Q This work is supported by NIH grant, U2C- DK119886.


Project ID: PR001035
Project DOI:doi: 10.21228/M8X39Q
Project Title:Untargeted metabolomics analysis of A549 cancer cells treated in vitro and in vivo by control (DMSO) or DRB18
Project Type:Untargeted quantitative metabolomics analysis
Project Summary:DR18, a novel anticancer compound was used to A549 lung cancer cells in vitro and A549 cell line derived xenograft tumors in vivo in nude mice. The untargeted metabolomics data was generated from these studies.
Institute:Ohio University
Department:Biological Sciences
Laboratory:Dr. Xiaozhuo Chen, Edison biotechnology Institute
Last Name:Shriwas
First Name:Pratik
Address:172 Water Tower, Building 25, The Ridges, Konnekar Research Centerm Athens Ohio - 45701, USA
Contributors:Campus Chemical Instrument Center, Ohio State University

Summary of all studies in project PR001035

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
(* : Contains raw data)
ST001610 Control (DMSO 0.1%; v/v) and 10 ┬ÁM DRB18 treated A549 lung cancer cells in vitro for 48 hours Homo sapiens Ohio University MS 2020-12-09 1 18 Uploaded data (9.3G)*
ST001638 Metabolomics analysis of Vehicle (DMSO/PBS; (1:1) v/v) and DRB18 (10 mg/kg) treated A549 xenograft tumors Mus musculus Ohio University MS 2021-04-01 1 24 Uploaded data (1.8G)*